卡塔托尼慢性病:当洛拉泽帕姆挑战显示出延迟反应时
Chaden Noureddine1, Emil Achmad2
1Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Case reports in psychiatry
|October 20, 2025
概括
本案例研究强调了一名年轻男子被诊断患有白内障,主要表现为认知障碍. 洛拉泽帕姆挑战测试 (LCT) 揭示了延迟反应,挑战了这种复杂疾病的传统诊断时间表.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 卡塔托尼症是一种复杂的综合征,具有运动和认知症状,历史上与精神分裂症有关,但现在在更广泛的背景下得到了认可.
- "DSM-5"扩展了猫的诊断标准,承认其与各种精神和身体健康状况的关联.
- 洛拉泽巴姆挑战测试 (LCT) 是一种用于治疗白内障的标准诊断和治疗工具.
研究的目的:
- 呈现一种主要表现为认知障碍的猫症病例.
- 挑战洛拉泽帕姆挑战测试 (LCT) 的常规诊断时间表.
- 为了强调诊断复杂的catatonia,特别是它的认知表现.
主要方法:
- 一份病例报告详细介绍了一名年轻的男性患者的认知障碍.
- 进行传统的2毫克洛拉泽帕姆挑战测试 (LCT).
- 在长时间内观察患者对LCT的反应.
主要成果:
- 根据LCT,该患者被诊断出患有白内障.
- 最初对LCT的负面反应之后几个小时后出现了显著的症状改善.
- 及时诊断和干预导致症状改善和减少住院时间.
结论:
- 这一案例表明,需要重新考虑LCT的标准评估时间表.
- 病理生理学和最佳治疗反应,包括lorazepam的作用,需要进一步调查.
- 进一步的研究是必要的,以了解catatonia的各种表现,诊断和治疗.
相关概念视频
Psychosis: Goals of Pharmacotherapy
466
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
466
CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.3K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.3K


